Free shipping over €250 · Tracked, discreet delivery in Europe

Growth hormone receptor antagonist

Pegvisomant

Somavert

Approved medicineNot yet reviewedProtein

In short: A modified growth hormone that blocks its own receptor. Approved for acromegaly.

Regulatory status

  1. Cosmetic ingredient
  2. Research compound
  3. In clinical trials
  4. Approved medicine

Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Common questions

Is Pegvisomant an approved medicine?

Approved medicine. Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.

How much human research is there on Pegvisomant?

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Does UU supply Pegvisomant?

No. It appears in the library for reference only, so the field can be read in one place.

More in Hormones & growth

Back to the library

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.